Literature DB >> 17088866

(+/-)-Naringenin as large conductance Ca(2+)-activated K+ (BKCa) channel opener in vascular smooth muscle cells.

S Saponara1, L Testai, D Iozzi, E Martinotti, A Martelli, S Chericoni, G Sgaragli, F Fusi, V Calderone.   

Abstract

UNLABELLED: BACKGROUND AND PURPOSE. The aim of this study was to investigate, in vascular smooth muscle cells, the mechanical and electrophysiological effects of (+/-)-naringenin. EXPERIMENTAL APPROACH: Aorta ring preparations and single tail artery myocytes were employed for functional and patch-clamp experiments, respectively. KEY
RESULTS: (+/-)-Naringenin induced concentration-dependent relaxation in endothelium-denuded rat aortic rings pre-contracted with either 20 mM KCl or noradrenaline (pIC(50) values of 4.74 and 4.68, respectively). Tetraethylammonium, iberiotoxin, 4-aminopyridine and 60 mM KCl antagonised (+/-)-naringenin-induced vasorelaxation, while glibenclamide did not produce any significant antagonism. Naringin [(+/-)-naringenin 7-beta-neohesperidoside] caused a concentration-dependent relaxation of rings pre-contracted with 20 mM KCl, although its potency and efficacy were significantly lower than those of (+/-)-naringenin. In rat tail artery myocytes, (+/-)-naringenin increased large conductance Ca(2+)-activated K(+) (BK(Ca)) currents in a concentration-dependent manner; this stimulation was iberiotoxin-sensitive and fully reversible upon drug wash-out. (+/-)-Naringenin accelerated the activation kinetics of BK(Ca) current, shifted, by 22 mV, the voltage dependence of the activation curve to more negative potentials, and decreased the slope of activation. (+/-)-Naringenin-induced stimulation of BK(Ca) current was insensitive either to changes in the intracellular Ca(2+) concentration or to the presence, in the pipette solution, of the fast Ca(2+) chelator BAPTA. However, such stimulation was diminished when the K(+) gradient across the membrane was reduced. CONCLUSIONS AND IMPLICATIONS: The vasorelaxant effect of the naturally-occurring flavonoid (+/-)-naringenin on endothelium-denuded vessels was due to the activation of BK(Ca) channels in myocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17088866      PMCID: PMC2014637          DOI: 10.1038/sj.bjp.0706951

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

Review 1.  International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels.

Authors:  Aguan D Wei; George A Gutman; Richard Aldrich; K George Chandy; Stephan Grissmer; Heike Wulff
Journal:  Pharmacol Rev       Date:  2005-12       Impact factor: 25.468

2.  Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells.

Authors:  A Fabiato; F Fabiato
Journal:  J Physiol (Paris)       Date:  1979

3.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

4.  4-aminopyridine affects rat arterial smooth muscle BK(Ca) currents by changing intracellular pH.

Authors:  P Petkova-Kirova; H Gagov; U Krien; D Duridanova; T Noack; R Schubert
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

5.  Effects of quercetin and rutin on vascular preparations: a comparison between mechanical and electrophysiological phenomena.

Authors:  Fabio Fusi; Simona Saponara; Federica Pessina; Beatrice Gorelli; Giampietro Sgaragli
Journal:  Eur J Nutr       Date:  2003-01       Impact factor: 5.614

6.  Downregulation of the BK channel beta1 subunit in genetic hypertension.

Authors:  Gregory C Amberg; L Fernando Santana
Journal:  Circ Res       Date:  2003-10-09       Impact factor: 17.367

7.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study.

Authors:  M G Hertog; E J Feskens; P C Hollman; M B Katan; D Kromhout
Journal:  Lancet       Date:  1993-10-23       Impact factor: 79.321

8.  Vasodilator effects of quercetin in isolated rat vascular smooth muscle.

Authors:  J Duarte; F Pérez-Vizcaíno; A Zarzuelo; J Jiménez; J Tamargo
Journal:  Eur J Pharmacol       Date:  1993-08-03       Impact factor: 4.432

9.  L-type Ca2+ channels activation and contraction elicited by myricetin on vascular smooth muscles.

Authors:  Fabio Fusi; Simona Saponara; Maria Frosini; Beatrice Gorelli; Giampietro Sgaragli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-15       Impact factor: 3.000

10.  Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta.

Authors:  Machha Ajay; Anwar-ul Hassan Gilani; Mohd Rais Mustafa
Journal:  Life Sci       Date:  2003-12-19       Impact factor: 5.037

View more
  27 in total

1.  Vasorelaxant effect of FR900359 from Ardisia crenata on rat aortic artery.

Authors:  Kazumasa Zaima; Jun Deguchi; Yosuke Matsuno; Toshio Kaneda; Yusuke Hirasawa; Hiroshi Morita
Journal:  J Nat Med       Date:  2012-03-03       Impact factor: 2.343

Review 2.  Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action.

Authors:  M Ashraful Alam; Nusrat Subhan; M Mahbubur Rahman; Shaikh J Uddin; Hasan M Reza; Satyajit D Sarker
Journal:  Adv Nutr       Date:  2014-07-14       Impact factor: 8.701

3.  The flavonoid scaffold as a template for the design of modulators of the vascular Ca(v) 1.2 channels.

Authors:  S Saponara; E Carosati; P Mugnai; G Sgaragli; F Fusi
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

4.  Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin-Q.

Authors:  Tin T Yow; Elena Pera; Nathan Absalom; Marika Heblinski; Graham A R Johnston; Jane R Hanrahan; Mary Chebib
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

5.  Vasorelaxant activity of indole alkaloids from Tabernaemontana dichotoma.

Authors:  Kazumasa Zaima; Ikumi Koga; Nobuhide Iwasawa; Takahiro Hosoya; Yusuke Hirasawa; Toshio Kaneda; Intan Safinar Ismail; Nordin Hj Lajis; Hiroshi Morita
Journal:  J Nat Med       Date:  2012-02-21       Impact factor: 2.343

Review 6.  An ethnopharmacological review on the therapeutical properties of flavonoids and their mechanisms of actions: A comprehensive review based on up to date knowledge.

Authors:  Doha H Abou Baker
Journal:  Toxicol Rep       Date:  2022-03-14

7.  Naringenin attenuates pressure overload-induced cardiac hypertrophy.

Authors:  Ning Zhang; Zheng Yang; Yuan Yuan; Fangfang Li; Yuan Liu; Zhenguo Ma; Haihan Liao; Zhouyan Bian; Yao Zhang; Heng Zhou; Wei Deng; Mengqiao Zhou; Qizhu Tang
Journal:  Exp Ther Med       Date:  2015-10-19       Impact factor: 2.447

8.  Citrus flavonoid naringenin improves aortic reactivity in streptozotocin-diabetic rats.

Authors:  Faramarz Fallahi; Mehrdad Roghani; Sanaz Moghadami
Journal:  Indian J Pharmacol       Date:  2012-05       Impact factor: 1.200

9.  Naringenin inhibits the growth of Dictyostelium and MDCK-derived cysts in a TRPP2 (polycystin-2)-dependent manner.

Authors:  A Waheed; M H R Ludtmann; N Pakes; S Robery; A Kuspa; C Dinh; D Baines; R S B Williams; M A Carew
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 10.  Potential Benefits of Flavonoids on the Progression of Atherosclerosis by Their Effect on Vascular Smooth Muscle Excitability.

Authors:  Rosa Edith Grijalva-Guiza; Aura Matilde Jiménez-Garduño; Luis Ricardo Hernández
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.